Kenneth J Kellar Selected Research

Kenneth J Kellar Research Topics

6	Tobacco Use Disorder (Nicotine Dependence) 08/2015 - 01/2008
3	Body Weight (Weight, Body) 01/2020 - 11/2016
2	Cognitive Dysfunction 02/2024 - 06/2011
2	Hypothermia 10/2013 - 05/2012
2	Autism Spectrum Disorder 12/2011 - 10/2005
1	Memory Disorders (Memory Loss) 02/2024
1	Major Depressive Disorder (Major Depressive Disorders) 01/2020
1	Anhedonia 01/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2017
1	Depressive Disorder (Melancholia) 02/2016
1	Mood Disorders (Mood Disorder) 02/2016
1	Blepharoptosis (Ptosis, Eyelid) 02/2016
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 05/2014
1	Weight Gain 05/2014
1	Central Nervous System Diseases (CNS Diseases) 04/2014
1	Alcoholism (Alcohol Abuse) 04/2013
1	Mental Disorders (Mental Disorder) 06/2011
1	Seizures (Absence Seizure) 09/2008
1	Pain (Aches) 09/2008
1	Insulinoma 03/2006
1	Neoplasms (Cancer) 04/2005
1	Carcinogenesis 04/2005
1	Lung Neoplasms (Lung Cancer) 04/2005

12	Nicotine FDA Link 01/2020 - 04/2005
10	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2020 - 04/2005
8	sazetidine-AIBA 11/2016 - 09/2008
2	3- (azetidin- 2- ylmethoxy)- 5- (phenylethynyl)pyridineIBA 09/2017 - 10/2013
2	Cholinergic ReceptorsIBA 04/2014 - 04/2013
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2024
1	Glutamic Acid (Glutamate)FDA Link 02/2024
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2024
1	Antidepressive Agents (Antidepressants)IBA 01/2020
1	YL-2-203IBA 09/2017
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 11/2016
1	LigandsIBA 11/2016
1	MelanocortinsIBA 11/2016
1	Methadone (Dolophine)FDA LinkGeneric 02/2016
1	MecamylamineIBA 02/2016
1	Irritants (Vesicants)IBA 08/2015
1	SmokeIBA 08/2015
1	Anti-Anxiety Agents (Anxiolytics)IBA 05/2014
1	pyridineIBA 04/2013
1	Analgesics (Analgesic Drugs)IBA 09/2008
1	epibatidineIBA 09/2008
1	Formaldehyde (Formol)FDA Link 09/2008
1	RubidiumIBA 03/2006
1	Insulin (Novolin)FDA Link 03/2006
1	CalciumIBA 03/2006